insights_auto
Why is IOVA down 4.23%?
Dive Deeperchevron_right
IOVA:NASDAQ
Iovance Biotherapeutics Inc
$10.19
arrow_downward
-4.23%(-0.45) 1D
$10.19
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IOVA...
Open
$10.69
High
$10.84
Low
$10.12
Mkt. cap
4.62B
Avg. vol.
15.25M
Volume
15.78M
52-wk high
$10.98
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
Open
$10.69
High
$10.84
Low
$10.12
Mkt. cap
4.62B
Avg. vol.
15.25M
Volume
15.78M
52-wk high
$10.98
52-wk low
$1.76
EPS
-$0.72
Beta
0.83
Shares outstanding
452.97M
No. of employees
975
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Is Record Quarter Altering The Investment Case For Iovance Stock (IOVA)?
AD HOC NEWS
·
1 day ago
Iovance Biotherapeutics stock extends rally after strong earnings and cancer therapy momentum
Zacks
·
2 days ago
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteiovance.com